Skip to main content
Clinical Trials/NCT02901405
NCT02901405TerminatedNot Applicable

Negative Pressure Dressings Versus Non-negative Pressure Dressing for Wound Care Following Soft Tissue Sarcoma Excision

NHS Greater Glasgow and Clyde2 sites in 1 country17 target enrollmentStarted: October 18, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
17
Locations
2
Primary Endpoint
Surgical Site Infection (proportion)

Study Overview

Brief Summary

This randomised controlled trial aims to evaluate the difference in surgical site infection following excision of soft tissue sarcomas. The intervention is a negative wound pressure therapy dressing for 120 hours, the control is standard absorbent dressings

Detailed Description

Hypothesis

The application of a negative pressure wound therapy (NPWT) dressing will reduce rates of wound breakdown in patients with resection of soft tissue sarcomas which are primarily closed.

Patients will be randomised into either NPWT or standard absorbent dressings with primary outcome measure of surgical site infection according to the Health Protection Agency guidance. Secondary outcomes are; time to wound dryness, delayed discharge from hospital, adverse events, cost estimation

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults undergoing primary soft tissue sarcoma excision which is primarily closed.

Exclusion Criteria

  • Unable to consent
  • Post radiation sarcomas or sarcoma in presence of active infection
  • Multiple metastatic disease
  • Presence of Endoprosthesis

Outcomes

Primary Outcomes

Surgical Site Infection (proportion)

Time Frame: 30 days

As diagnosed by independent observer according to the Healthcare Protection Agency (UK) guidelines

Secondary Outcomes

  • Delay to discharge form hospital (nominal scale)(30 days)
  • Adverse events (count)(30 days)
  • Cost analysis (comparative nominal scale in £)(30 days)
  • Time to wound dryness (nominal scale)(30 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials